BCL2 and epilepsy: Bcl-2 upregulation in refractory epilepsy neurons significantly decreased cell apoptosis to 60.0% ± 7.1% (P < 0.05), which showed that Bcl-2 acted as an anti-apoptotic protein in this epilepsy model.